A dual role of Irf1 in maintaining epithelial identity but also enabling EMT and metastasis formation of breast cancer cells
- 14 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 39 (24), 4728-4740
- https://doi.org/10.1038/s41388-020-1326-0
Abstract
An epithelial to mesenchymal transition (EMT) is an embryonic dedifferentiation program which is aberrantly activated in cancer cells to acquire cellular plasticity. This plasticity increases the ability of breast cancer cells to invade into surrounding tissue, to seed metastasis at distant sites and to resist to chemotherapy. In this study, we have observed a higher expression of interferon-related factors in basal-like and claudin-low subtypes of breast cancer in patients, known to be associated with EMT. Notably, Irf1 exerts essential functions during the EMT process, yet it is also required for the maintenance of an epithelial differentiation status of mammary gland epithelial cells: RNAi-mediated ablation of Irf1 in mammary epithelial cells results in the expression of mesenchymal factors and Smad transcriptional activity. Conversely, ablation of Irf1 during TGFβ-induced EMT prevents a mesenchymal transition and stabilizes the expression of E-cadherin. In the basal-like murine breast cancer cell line 4T1, RNAi-mediated ablation of Irf1 reduces colony formation and cell migration in vitro and shedding of circulating tumor cells and metastasis formation in vivo. This context-dependent dual role of Irf1 in the regulation of epithelial-mesenchymal plasticity provides important new insights into the functional contribution and therapeutic potential of interferon-regulated factors in breast cancer.Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030B_163471, SystemsX.ch RTD Cellplasticity, Marie-Heim-Vögtlin Fellowship)
- Krebsliga Beider Basel (03-2013)
- Krebsliga Schweiz (KFS-3479-08-2014)
This publication has 34 references indexed in Scilit:
- The shaping and functional consequences of the microRNA landscape in breast cancerNature, 2013
- An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor ResistanceClinical Cancer Research, 2013
- Py2T Murine Breast Cancer Cells, a Versatile Model of TGFβ-Induced EMT In Vitro and In VivoPLOS ONE, 2012
- The IRF family of transcription factorsOncoImmunology, 2012
- Cas and NEDD9 Contribute to Tumor Progression through Dynamic Regulation of the CytoskeletonGenes & Cancer, 2012
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroupsNature, 2012
- Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancerBreast Cancer Research, 2010
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic SubtypesJournal of Clinical Oncology, 2009
- EMT, the cytoskeleton, and cancer cell invasionCancer and Metastasis Reviews, 2009
- NCAM-induced focal adhesion assembly: a functional switch upon loss of E-cadherinThe EMBO Journal, 2008